This brand name is authorized in Malta, Netherlands, United Kingdom
The drug PERFAN contains one active pharmaceutical ingredient (API):
1
Enoximone
UNII C7Z4ITI7L7 - ENOXIMONE
|
Enoximone, an imidazolone, has both positive inotropic and vasolidator properties, inhibiting cardiac phosphodiesterase III with an increase in cAMP. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PERFAN Concentrate for solution for injection or infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C01CE03 | Enoximone | C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CE Phosphodiesterase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 40836 |
Country: MT | Medicines Authority | Identifier(s): AA565/42501 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14628147 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 29386 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.